Growth Metrics

ClearPoint Neuro (CLPT) Cash from Operations Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -29.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -29.08%
Dec 31, 2025 -869.83%
Sep 30, 2025 -160.30%
Jun 30, 2025 4.35%
Mar 31, 2025 -60.73%
Dec 31, 2024 -6.33%
Sep 30, 2024 33.24%
Jun 30, 2024 47.43%
Mar 31, 2024 32.39%
Dec 31, 2023 61.86%
Sep 30, 2023 53.37%
Jun 30, 2023 -1.89%
Mar 31, 2023 -33.05%
Dec 31, 2022 13.71%
Sep 30, 2022 -16.87%
Jun 30, 2022 -33.97%
Mar 31, 2022 -100.33%
Dec 31, 2021 -47.94%
Sep 30, 2021 -141.11%
Jun 30, 2021 -117.68%
Mar 31, 2021 8.58%
Dec 31, 2020 -414.91%
Sep 30, 2020 -41.79%
Jun 30, 2020 -110.84%
Mar 31, 2020 -282.47%
Dec 31, 2019 19.93%
Sep 30, 2019 1.14%
Jun 30, 2019 27.17%
Mar 31, 2019 68.92%
Mar 31, 2016 42.53%
Dec 31, 2015 27.29%
Sep 30, 2015 26.29%
Jun 30, 2015 -69.45%
Mar 31, 2015 -105.95%
Dec 31, 2014 925.99%
Sep 30, 2014 -18.53%
Jun 30, 2014 21.22%
Mar 31, 2014 39.40%
Dec 31, 2013 32.00%
Sep 30, 2013 6.13%
Jun 30, 2013 -59.78%
Mar 31, 2013 -19.04%
Dec 31, 2012 -54.99%
Sep 30, 2012 -47.70%
Jun 30, 2012 28.40%
Mar 31, 2012 -20.12%